CD19+ B-cell depletion (count < 0.07 × 109/L) occurred in 75.0% (9/12) with CLL, 100% (13/13) of the patients with FL, and 100% (23/23) with DLBCL. This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.